Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma.

about

Graft versus tumor effect in the brain of a child with recurrent metastatic medulloblastoma.

Item

http://www.wikidata.org/entity/Q46073972

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@en

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@nl

type

Item

label

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@en

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@nl

prefLabel

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@en

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@nl

P1476

Graft versus tumor effect in t ...... nt metastatic medulloblastoma.

@en

P2093

Hisham Abdel-Azim

http://www.w3.org/2001/XMLSchema#string

Jonathan L Finlay

http://www.w3.org/2001/XMLSchema#string

Kris M Mahadeo

http://www.w3.org/2001/XMLSchema#string

Neena Kapoor

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.

The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells

The allogeneic graft-versus-cancer effect.

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.

Successful treatment with reduced-intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma.

Regression of experimental medulloblastoma following transfer of HER2-specific T cells.

P304

1667-1669

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25525

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25894457

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma